Yasuto Otsubo

Review Director
PMDA

Mr. Yasuto Otsubo is currently a review director of Office of New Drug II at Pharmaceuticals & Medical Devices Agency (PMDA). In this position, he is responsible for reviewing cardiovascular drugs, antiparkinsonian drugs, and anti-Alzheimer's drugs. He has over 15 years' experience in the regulatory agencies. He has been a member of multi-regional clinical trial working group (MRCT WG) at PMDA and has served on promoting MRCT.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• Clinical Trial Diversity & Inclusion: How Clinical Pharmacology Can Support the Implementation of Regulatory Guidance on Diversity Plans

  Tuesday, March 26, 2024
  8:30 AM – 5:30 PM MDT